Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050508

Expand all

CYCLAPEN-W (CYCLACILLIN)
125MG/5ML
Marketing Status: Discontinued

Active Ingredient: CYCLACILLIN
Proprietary Name: CYCLAPEN-W
Dosage Form; Route of Administration: FOR SUSPENSION; ORAL
Strength: 125MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050508
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

CYCLAPEN-W (CYCLACILLIN)
250MG/5ML
Marketing Status: Discontinued

Active Ingredient: CYCLACILLIN
Proprietary Name: CYCLAPEN-W
Dosage Form; Route of Administration: FOR SUSPENSION; ORAL
Strength: 250MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050508
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information

CYCLAPEN-W (CYCLACILLIN)
500MG/5ML
Marketing Status: Discontinued

Active Ingredient: CYCLACILLIN
Proprietary Name: CYCLAPEN-W
Dosage Form; Route of Administration: FOR SUSPENSION; ORAL
Strength: 500MG/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050508
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH AYERST LABORATORIES
Marketing Status:  Discontinued
Patent and Exclusivity Information